Search Results for NPPA

Showing 1 – 10

Asia Regulatory Roundup: Pfizer Asks TGA to Rethink Timeline for Biologics AE Reporting (14 March 2017) By Nick Paul Taylor - Published 14 March 2017

Welcome to our Asia Regulatory Roundup, our weekly overview of the top regulatory news in Asia.

Categories: News, Asia, CDSCO, TGA, Biologics and biotechnology, Drugs, Medical Devices

Tags: Asia Regulatory Roundup, Pfizer, NPPA, stents

Asia Regulatory Roundup: TGA Increases Inspections Following Adoption of Risk-Based Approach (7 March 2017) By Nick Paul Taylor - Published 07 March 2017

Welcome to our Asia Regulatory Roundup, our weekly overview of the top regulatory news in Asia.

Categories: News, Asia, CDSCO, CFDA, TGA, Biologics and biotechnology, Drugs, Government affairs, Manufacturing, Regulatory intelligence, Regulatory strategy

Tags: Asia Regulatory Roundup, TGA inspections, NPPA

Asia Regulatory Roundup: Quality Issues Push TGA to Seek New Source for Angina Drugs (2 August 2016) By Nick Paul Taylor - Published 02 August 2016

Welcome to our Asia Regulatory Roundup, our weekly overview of the top regulatory news in Asia.

Categories: News, Asia, CDSCO, CFDA, TGA, Drugs, Medical Devices, Quality

Tags: Angina, Arrow Pharmaceuticals, drug manufacturing inspections, DRAP, NPPA

Asia Regulatory Roundup: CFDA Offers Guidance on Revised Vaccine Distribution Regulations (21 June 2016) By Nick Paul Taylor - Published 21 June 2016

Welcome to our Asia Regulatory Roundup, our weekly overview of the top regulatory news in Asia.

Categories: News, Asia, CDSCO, CFDA, Biologics and biotechnology, Drugs, Government affairs, Manufacturing

Tags: vaccine distribution in China, FDC manufacturers in India, NPPA

Asia Regulatory Roundup: China FDA Seeks Comment on Generic Drug Quality Guidance (24 November 2015) By Nick Paul Taylor - Published 24 November 2015

Welcome to our Asia Regulatory Roundup, our weekly overview of the top regulatory news in Asia.

Categories: News, Asia, CDSCO, CFDA, Biologics and biotechnology, Drugs, Government affairs, Manufacturing, Quality, Research and development

Tags: Pakistan, India, China, NPPA, FIA, DRAP, CFDA

Asia Regulatory Roundup: China Looks to Revamp Drug Approval Process (3 November 2015) By Nick Paul Taylor - Published 03 November 2015

Welcome to our Asia Regulatory Roundup, our weekly overview of the top regulatory news in Asia.

Categories: News, Asia, Middle East, CFDA, MHLW, PMDA, Drugs, Manufacturing, Medical Devices, Regulatory intelligence, Regulatory strategy, Research and development

Tags: Asia regulations, CFDA, fast-track approval, NPPA, cough syrup

India Looks to Cap Prices of 12 Cancer Drugs as Nation Looks to Expand Price Controls By Michael Mezher - Published 05 May 2015

The cost of 12 cancer drugs could soon be capped in India if a recommendation from the country's National Pharmaceutical Pricing Authority (NPPA) is approved, The Indian Express reports.

Categories: News, India, CDSCO, Drugs, Government affairs

Tags: National Pharmaceutical Pricing Authority, NPPA, National List of Essential Medicines

Indian Parliament Proposes Extending Price Caps to all Drugs By Michael Mezher - Published 22 April 2015

Just weeks after India's drug pricing chief was ousted, a parliamentary committee has proposed expanding price caps to all drugs.

Categories: News, India, Drugs, Government affairs, Labeling

Tags: National Pharmaceutical Pricing Authority, NPPA, Drug Price Control Order

India's Drug Pricing Authority Announces Stiff Fines for Violators of Price Limits By Alexander Gaffney, RF News Editor - Published 26 October 2012

Categories: India

Tags: DPCO, Pricing, Fines, MRP, NPPA, Latest News, pharmaceutical, drug

India Poised to Restrict Price Hikes, Cut Margins By Alexander Gaffney - Published 05 January 2012

Categories: India

Tags: Maximum Retail Price, MRP, Imported, Profit, Price, NPPA, cost, Latest News